Could a common treatment preserve brain function after COVID-19 infection?

An innovative study to assess whether a commonly used cholesterol lowering medication can prevent brain complications from COVID-19 has received over $2.3m from the Government’s Medical Research Future Fund. The study, a collaboration between The George Institute for Global Health, the University of New South Wales, Monash University’s School of Public Health, University of Sydney
Read more...

;